This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ross, S. E.
Right arrow Articles by MacDougald, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, S. E.
Right arrow Articles by MacDougald, O. A.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, January 2004, p. 675-686, Vol. 24, No. 2
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.2.675-686.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Phosphorylation of C/EBP{alpha} Inhibits Granulopoiesis

Sarah E. Ross,1,{dagger} Hanna S. Radomska,2,{dagger} Bo Wu,3 Pu Zhang,2 Jonathon N. Winnay,1 Laszlo Bajnok,1 Wendy S. Wright,1 Fred Schaufele,3 Daniel G. Tenen,2 and Ormond A. MacDougald1*

Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan,1 Hematology/Oncology Division, Harvard Institutes of Medicine, Harvard Medical School, Boston, Massachusetts,2 Metabolic Research Unit, Diabetes Center and Department of Medicine, University of California, San Francisco, California3

Received 19 May 2003/ Returned for modification 16 July 2003/ Accepted 14 October 2003

CCAAT/enhancer-binding protein {alpha} (C/EBP{alpha}) is one of the key transcription factors that mediate lineage specification and differentiation of multipotent myeloid progenitors into mature granulocytes. Although C/EBP{alpha} is known to induce granulopoiesis while suppressing monocyte differentiation, it is unclear how C/EBP{alpha} regulates this cell fate choice at the mechanistic level. Here we report that inducers of monocyte differentiation inhibit the alternate cell fate choice, that of granulopoiesis, through inhibition of C/EBP{alpha}. This inhibition is mediated by extracellular signal-regulated kinases 1 and/or 2 (ERK1/2), which interact with C/EBP{alpha} through an FXFP docking site and phosphorylate serine 21. As a consequence of C/EBP{alpha} phosphorylation, induction of granulocyte differentiation by C/EBP{alpha} or retinoic acid is inhibited. Our analysis of C/EBP{alpha} by fluorescent resonance energy transfer revealed that phosphorylation induces conformational changes in C/EBP{alpha}, increasing the distance between the amino termini of C/EBP{alpha} dimers. Thus, myeloid development is partly regulated by an ERK1/2-mediated change in the conformation of C/EBP{alpha} that favors monocyte differentiation by blocking granulopoiesis.


* Corresponding author. Mailing address: Department of Molecular and Integrative Physiology, University of Michigan Medical School, 1301 E. Catherine St., Ann Arbor, MI 48109-0622. Phone: (734) 647-4880. Fax: (734) 936-8813. E-mail: macdouga{at}umich.edu.

{dagger} S. E. Ross and H. S. Radomska contributed equally to this work.


Molecular and Cellular Biology, January 2004, p. 675-686, Vol. 24, No. 2
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.2.675-686.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Jack, G. D., Zhang, L., Friedman, A. D. (2009). M-CSF elevates c-Fos and phospho-C/EBP{alpha}(S21) via ERK whereas G-CSF stimulates SHP2 phosphorylation in marrow progenitors to contribute to myeloid lineage specification. Blood 114: 2172-2180 [Abstract] [Full Text]  
  • Pabst, T., Mueller, B. U. (2009). Complexity of CEBPA Dysregulation in Human Acute Myeloid Leukemia. Clin. Cancer Res. 15: 5303-5307 [Abstract] [Full Text]  
  • Geest, C. R., Coffer, P. J. (2009). MAPK signaling pathways in the regulation of hematopoiesis. J. Leukoc. Biol. 86: 237-250 [Abstract] [Full Text]  
  • Nowak, D., Stewart, D., Koeffler, H. P. (2009). Differentiation therapy of leukemia: 3 decades of development. Blood 113: 3655-3665 [Abstract] [Full Text]  
  • Cha, H. C., Oak, N. R., Kang, S., Tran, T.-A., Kobayashi, S., Chiang, S.-H., Tenen, D. G., MacDougald, O. A. (2008). Phosphorylation of CCAAT/Enhancer-binding Protein {alpha} Regulates GLUT4 Expression and Glucose Transport in Adipocytes. J. Biol. Chem. 283: 18002-18011 [Abstract] [Full Text]  
  • Iida, S., Watanabe-Fukunaga, R., Nagata, S., Fukunaga, R. (2008). Essential role of C/EBPalpha in G-CSF-induced transcriptional activation and chromatin modification of myeloid-specific genes.. GENES CELLS 13: 313-327 [Abstract] [Full Text]  
  • Buitenhuis, M., Verhagen, L. P., van Deutekom, H. W. M., Castor, A., Verploegen, S., Koenderman, L., Jacobsen, S.-E. W., Coffer, P. J. (2008). Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis. Blood 111: 112-121 [Abstract] [Full Text]  
  • Twu, Y.-C., Chen, C.-P., Hsieh, C.-Y., Tzeng, C.-H., Sun, C.-F., Wang, S.-H., Chang, M.-S., Yu, L.-C. (2007). I branching formation in erythroid differentiation is regulated by transcription factor C/EBP{alpha}. Blood 110: 4526-4534 [Abstract] [Full Text]  
  • Geletu, M., Balkhi, M. Y., Peer Zada, A. A., Christopeit, M., Pulikkan, J. A., Trivedi, A. K., Tenen, D. G., Behre, G. (2007). Target proteins of C/EBP{alpha}p30 in AML: C/EBP{alpha}p30 enhances sumoylation of C/EBP{alpha}p42 via up-regulation of Ubc9. Blood 110: 3301-3309 [Abstract] [Full Text]  
  • Chang, J. S., Santhanam, R., Trotta, R., Neviani, P., Eiring, A. M., Briercheck, E., Ronchetti, M., Roy, D. C., Calabretta, B., Caligiuri, M. A., Perrotti, D. (2007). High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBP{alpha}-driven myeloid differentiation. Blood 110: 994-1003 [Abstract] [Full Text]  
  • Datta, J., Majumder, S., Kutay, H., Motiwala, T., Frankel, W., Costa, R., Cha, H. C., MacDougald, O. A., Jacob, S. T., Ghoshal, K. (2007). Metallothionein Expression Is Suppressed in Primary Human Hepatocellular Carcinomas and Is Mediated through Inactivation of CCAAT/Enhancer Binding Protein {alpha} by Phosphatidylinositol 3-Kinase Signaling Cascade. Cancer Res. 67: 2736-2746 [Abstract] [Full Text]  
  • Padron, A., Li, L., Kofoed, E. M., Schaufele, F. (2007). Ligand-Selective Interdomain Conformations of Estrogen Receptor-{alpha}. Mol. Endocrinol. 21: 49-61 [Abstract] [Full Text]  
  • Hatzis, P., Kyrmizi, I., Talianidis, I. (2006). Mitogen-Activated Protein Kinase-Mediated Disruption of Enhancer-Promoter Communication Inhibits Hepatocyte Nuclear Factor 4{alpha} Expression.. Mol. Cell. Biol. 26: 7017-7029 [Abstract] [Full Text]  
  • Qiao, L., MacDougald, O. A., Shao, J. (2006). CCAAT/Enhancer-binding Protein {alpha} Mediates Induction of Hepatic Phosphoenolpyruvate Carboxykinase by p38 Mitogen-activated Protein Kinase. J. Biol. Chem. 281: 24390-24397 [Abstract] [Full Text]  
  • Wang, D., D'Costa, J., Civin, C. I., Friedman, A. D. (2006). C/EBP{alpha} directs monocytic commitment of primary myeloid progenitors. Blood 108: 1223-1229 [Abstract] [Full Text]  
  • Xu, Y., Zhou, Y. L., Luo, W., Zhu, Q.-S., Levy, D., MacDougald, O. A., Snead, M. L. (2006). NF-Y and CCAAT/Enhancer-binding Protein {alpha} Synergistically Activate the Mouse Amelogenin Gene. J. Biol. Chem. 281: 16090-16098 [Abstract] [Full Text]  
  • Radomska, H. S., Basseres, D. S., Zheng, R., Zhang, P., Dayaram, T., Yamamoto, Y., Sternberg, D. W., Lokker, N., Giese, N. A., Bohlander, S. K., Schnittger, S., Delmotte, M.-H., Davis, R. J., Small, D., Hiddemann, W., Gilliland, D. G., Tenen, D. G. (2006). Block of C/EBP{alpha} function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. JEM 203: 371-381 [Abstract] [Full Text]  
  • Blazek, D., Barboric, M., Kohoutek, J., Oven, I., Peterlin, B. M. (2005). Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb. Nucleic Acids Res 33: 7000-7010 [Abstract] [Full Text]  
  • Kortum, R. L., Costanzo, D. L., Haferbier, J., Schreiner, S. J., Razidlo, G. L., Wu, M.-H., Volle, D. J., Mori, T., Sakaue, H., Chaika, N. V., Chaika, O. V., Lewis, R. E. (2005). The Molecular Scaffold Kinase Suppressor of Ras 1 (KSR1) Regulates Adipogenesis. Mol. Cell. Biol. 25: 7592-7604 [Abstract] [Full Text]  
  • Helbling, D., Mueller, B. U., Timchenko, N. A., Schardt, J., Eyer, M., Betts, D. R., Jotterand, M., Meyer-Monard, S., Fey, M. F., Pabst, T. (2005). CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16). Blood 106: 1369-1375 [Abstract] [Full Text]  
  • Iida, S., Kohro, T., Kodama, T., Nagata, S., Fukunaga, R. (2005). Identification of CCR2, flotillin, and gp49B genes as new G-CSF targets during neutrophilic differentiation. J. Leukoc. Biol. 78: 481-490 [Abstract] [Full Text]  
  • Johnson, P. F. (2005). Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J. Cell Sci. 118: 2545-2555 [Abstract] [Full Text]  
  • Wang, G.-L., Timchenko, N. A. (2005). Dephosphorylated C/EBP{alpha} Accelerates Cell Proliferation through Sequestering Retinoblastoma Protein. Mol. Cell. Biol. 25: 1325-1338 [Abstract] [Full Text]  
  • Bienz, M., Ludwig, M., Mueller, B. U., Oppliger Leibundgut, E., Ratschiller, D., Solenthaler, M., Fey, M. F., Pabst, T. (2005). Risk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype. Clin. Cancer Res. 11: 1416-1424 [Abstract] [Full Text]  
  • Helbling, D., Mueller, B. U., Timchenko, N. A., Hagemeijer, A., Jotterand, M., Meyer-Monard, S., Lister, A., Rowley, J. D., Huegli, B., Fey, M. F., Pabst, T. (2004). The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. Proc. Natl. Acad. Sci. USA 101: 13312-13317 [Abstract] [Full Text]